Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoto Fujiwara

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Trends in Molecular Medicine|July 14, 2020
Viral Exposure Signature Associated with Liver Cancer RiskNaoto Fujiwara, Yujin Hoshida
Seminars in Liver Disease|March 27, 2019
Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with CirrhosisNaoto Fujiwara, Yujin Hoshida
Cancer Science|August 7, 2023
Clinico-histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver diseaseNaoto Fujiwara, Hayato Nakagawa
Journal of Clinical Medicine|December 1, 2020
Clinical and Molecular Prediction of Hepatocellular Carcinoma RiskNaoto Kubota, Naoto Fujiwara, Yujin Hoshida
Advances in Cancer Research|August 12, 2022
Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contextsNaoto Kubota, Naoto Fujiwara, Yujin Hoshida
Seminars in Liver Disease|April 4, 2024
Emerging Roles of Spatial Transcriptomics in Liver ResearchNaoto Fujiwara, Genki Kimura, Hayato Nakagawa
Hepatology (Baltimore, Md.)|June 18, 2019
Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular CarcinomaNaoto Fujiwara, Amit G Singal, Yujin Hoshida
Gastroenterology|May 4, 2025
ReplyNaoto Fujiwara, Amit G Singal, Yujin Hoshida
JTCVS Techniques|December 13, 2024
Imaging technology to assess tissue oxygen saturation of the gastric conduit in thoracic esophagectomyTakeo Fujita, Kazuma Sato, Naoto Fujiwara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2020
Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseasesNaoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, et al.
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Trends in Molecular Medicine|July 14, 2020
Viral Exposure Signature Associated with Liver Cancer RiskNaoto Fujiwara, Yujin Hoshida
Seminars in Liver Disease|March 27, 2019
Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with CirrhosisNaoto Fujiwara, Yujin Hoshida
Cancer Science|August 7, 2023
Clinico-histological and molecular features of hepatocellular carcinoma from nonalcoholic fatty liver diseaseNaoto Fujiwara, Hayato Nakagawa
Journal of Clinical Medicine|December 1, 2020
Clinical and Molecular Prediction of Hepatocellular Carcinoma RiskNaoto Kubota, Naoto Fujiwara, Yujin Hoshida
Advances in Cancer Research|August 12, 2022
Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contextsNaoto Kubota, Naoto Fujiwara, Yujin Hoshida
Seminars in Liver Disease|April 4, 2024
Emerging Roles of Spatial Transcriptomics in Liver ResearchNaoto Fujiwara, Genki Kimura, Hayato Nakagawa
Hepatology (Baltimore, Md.)|June 18, 2019
Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular CarcinomaNaoto Fujiwara, Amit G Singal, Yujin Hoshida
Gastroenterology|May 4, 2025
ReplyNaoto Fujiwara, Amit G Singal, Yujin Hoshida
JTCVS Techniques|December 13, 2024
Imaging technology to assess tissue oxygen saturation of the gastric conduit in thoracic esophagectomyTakeo Fujita, Kazuma Sato, Naoto Fujiwara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2020
Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseasesNaoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, et al.
Pageof 16